| 12/2/2019 4:21 pm Date / Time filed with the Register of Regulations | VA.R. Document Number: R____-______ |
|
Virginia Register Publication Information
|
Transmittal Sheet: Response to Petition for Rulemaking
X
Initial Agency Notice
Agency Decision
| Promulgating Board: | Board of Medicine |
| Regulatory Coordinator: | Elaine J. Yeatts (804)367-4688 elaine.yeatts@dhp.virginia.gov |
| Agency Contact: | William L. Harp, M.D. Executive Director (804)367-4558 william.harp@dhp.virginia.gov |
| Contact Address: | Department of Health Professions 9960 Mayland Drive Suite 300 Richmond, VA 23233 |
| Chapter Affected: | |
| 18 vac 85 - 21: | Regulations Governing Prescribing of Opioids and Buprenorphine |
| Statutory Authority: |
State: 54.1-2400 and 54.1-2928.2 Federal: |
| Date Petition Received | 12/02/2019 |
| Petitioner | Dr. Lee Tannenbaum |
To amend subsection I of 18VAC85-21-150 to allow prescribing of up to the FDA approved
limit of 32 mg QD.
Agency Plan
In accordance with Virginia law, the petition will be filed with the Register of Regulations
and published on December 23, 2019 and posted on the Virginia Regulatory Townhall
at www.townhall.virginia.gov. Comment on the petition will be requested until January
22, 2020 and may be posted on the Townhall or sent to the Board.
Following receipt of all comments on the petition to amend regulations, the matter
will be considered by the full Board at its meeting in February of 2020.
| Publication Date | 12/23/2019 (comment period will also begin on this date) |
| Comment End Date | 01/22/2020 |